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Introduction: The human hepatitis B virus causes acute and chronic hepatitis and is consid-
ered  one of the most serious human health issues by the World Health Organization, causing
thousands of deaths per year. There are similar viruses belonging to the Hepadnaviridae
family  that infect non-human primates and other mammals as well as some birds. The
majority  of non-human primate virus isolates were phylogenetically close to the human
hepatitis  B virus, but like the human genotypes, the origins of these viruses remain contro-
versial.  However, there is a possibility that human hepatitis B virus originated in primates.
Knowing  whether these viruses might be common to humans and primates is crucial in
order  to reduce the risk to humans.
Objective: To review the existing knowledge about the evolutionary origins of viruses of the
Hepadnaviridae family in primates.
Methods: This review was  done by reading several articles that provide information about the
Hepadnaviridae virus family in non-human primates and humans and the possible origins
and  evolution of these viruses.
Results:  The evolutionary origin of viruses of the Hepadnaviridae family in primates has
been  dated back to several thousand years; however, recent analyses of genomic fossils of
avihepadnaviruses integrated into the genomes of several avian species have suggested a
much older origin of this genus.
Conclusion:  Some hypotheses about the evolutionary origins of human hepatitis B virus havebeen  debated since the ‘90s. One theory suggested a New World origin because of the phylo-genetic co-segregation between some New World human hepatitis B virus genotypes F and
H  and woolly monkey human hepatitis B virus in basal sister-relationship to the Old World
non-human primates and human hepatitis B virus variants. Another theory suggests an
Old  World origin of human hepatitis B virus, and that it would have been spread following
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prehistoric human migrations over 100,000 years ago. A third theory suggests a co-speciation
of human hepatitis B virus in non-human primate hosts because of the proximity between
the phylogeny of Old and New World non-human primate and their human hepatitis B virus
variants. The importance of further research, related to the subject in South American wild
fauna, is paramount and highly relevant for understanding the origin of human hepatitis B
virus.
© 2014 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroduction
The human hepatitis B virus (HBV) is a small enveloped DNA
virus  that causes two forms of hepatitis – acute and chronic.
The  World Health Organization (WHO) estimates that more
than  1/3 of the world population already possess serologic
evidence of HBV infection, 350 million people are chronically
infected and approximately 600,000 deaths are reported each
year  as a result of acute or chronic hepatitis B.1,2 Infected
patients have a high risk of developing serious problems
related to the disease, such as ﬁbrosis, cirrhosis and hepatocel-
lular  carcinoma (HCC).3 Today, HCC is the ﬁfth most frequent
human  cancer.4,5
A prophylactic vaccine against a subunit of the hepati-
tis  B surface antigen (HBs) is already available. However,
there can be failures in some cases such as emerging
anti-HBs-escape mutant viruses, patients with compromised
immune-response or heterologous HBV genotypes.6–8 Despite
the  safety and efﬁcacy of the developed vaccines, infection
with  hepatitis B virus (HBV) continues to persist as a public
health  problem and a leading cause of death from infectious
diseases worldwide. HBV can be divided into at least ten geno-
types  (A–J), distinguished by more  than an 8% difference in
their  genomic nucleotide sequence. There are variations in the
geographical  distribution of HBV genotypes. While the geno-
types  A, D and G are detected all over the world, genotypes
B,  C, I and J are most common in Asia, genotype F and H in
Native  Americans, and genotype E can be found in Western
Africa.9–11
The Hepadnaviridae family is made up of genera Orthohep-
adnavirus and Avihepadnavirus. The former infects mammals
and  is represented by: HBV (Hepatitis B Virus), which infects
humans;  viruses similar to HBV (such as woolly monkey HBV
and  orangutan-HBV for example), which infect non-human
primates; Woodchuck hepatitis virus (WHV) that causes hep-
atitis  in woodchucks, and Ground squirrel hepatitis virus
(GSHV)  causing hepatitis in squirrels.12,13 The latter infect
birds,  including Duck hepatitis B virus (DHBV) responsible
for  duck hepatitis and Heron hepatitis B virus (HHBV) which
causes  hepatitis in herons.14–16
General  characteristics  of  Hepadnaviridae
familyHepadnaviridae family members have as common character-
istics  a tropism for liver cells. They also possess enveloped
virions and icosahedral nucleocapsid; the genome consists ofan incomplete double stranded DNA with their own DNA poly-
merase,  which is a long negative strand and a short positive
strand,  with the latter of a variable length, depending on each
species.  They produce subviral particles; generate persistent
infection and replicate through RNA intermediate via reverse
transcriptase.17
The genome of human HBV (which is the prototype species
of  the family Hepadnaviridae) has a peculiar genomic orga-
nization  with a mechanism of asymmetric replication. This
genome  is relaxed circular and has a length of approximately
3200 base pairs and has four regions of open reading frame[s?]
(ORF)  which overlap: Pré-S1/Pré-S2/S, Pre C/C, X and P. These
genes  are responsible for encoding the three envelope (or
surface)  proteins; small (S), medium (M), and large (L), that
constitute  the HBV surface antigen (HBsAg), the core protein
(HBcAg),  the nuclear protein (HBeAg), X protein (that can affect
viral  replication and proliferation, and interfere in cellular pro-
cesses of apoptosis and carcinogenesis) and viral polymerase
(P).18,19 The ORF of the P gene occupies 80% of the entire
genome and encodes the viral DNA polymerase enzyme which
has  three areas: DNA polymerase, reverse transcriptase and
RNAase.  To better describe mutations in this gene, the reverse
transcriptase domain was  sub-divided into 7 sub-domains,
classiﬁed A–G.17,18,20 Mutations in the P gene cause a large
increase in the synthesis of viral DNA and greater risk of liver
carcinogenesis.18
Another characteristic is that hepatitis B is a non-retroviral
virus that uses reverse transcriptase as part of its replication
process, using the ‘covalently closed circular DNA’ (cccDNA),
which  serves as a template for transcription of four viral
mRNAs  and allows the maintenance of chronic HBV infection
in  hosts.21
HBV  in  primates
Besides human HBV, which is the model species of the family,
there  are viruses belonging to the same family that infect other
primates  (Table 1). Non-human HBV genotypes were  found in
higher Old World primates.22,23 Together with the high diver-
sity  of African HBV subgenotypes and recombinants, this led
to  the possibility that the origin of HBV occurred in Old World
primates.23,24 Most isolates from non-human primates (NHP)
were  phylogenetically close to human HBV isolates. Viruses
were  found in gibbons (Nomascus sp. and Hylobates sp.),25
26–29 30chimpanzees (Pan troglodytes), gorillas (Gorilla gorilla) and
orangutans (Pongo pygmaeus)31 (Fig. 1).
The  origin of these viruses remains controversial. Chim-
panzees  from different regions of the planet appear to be
b r a z j i n f e c t d i s . 2 0 1 4;1 8(5):535–543  537
Table 1 – Characteristics of previous publications about HBV infections in primates: PCR detection, HBsAg, HBcAb,
genotypes and observations.
Publications Non-human primates
species
PCRa HBsAga–HBcAba Genotypes and observations
Great monkeys (apes)
Lyons et al.22 (Cameroon – tested
in United Kingdom)
Pan troglodytes
spp.
51/268 58/810–10/14 chHBV.  Evidence for a
recombination  between goHBV
and ch-derived HBV
Njouom et al.59 (Cameroon) chHBV. Recombination
between HBV P. t. troglodytes
and  P. t. vellerosus strains
Makuwa et al.60 (Cameroon,
Republic of Congo and Gabon)
chHBV
Makuwa  et al.61 (Republic of Congo
and Gabon)
–
Starkman et al.23 (Cameroon –
tested in United Kingdom)
chHBV
Takahashi  et al.29 (Sierraleone and
Gabon)
chHBV, that can be a
recombination  between
human  HBV and go/ch HBV
Hu et al.27 (USA) chHBV
MacDonald et al.28 (Cameroon and
United Kingdom)
chHBV
Hu  et al.26 (USA) chHBV
Takahashi et al.51 (Liberia) chHBV
Grethe et al.30 (Germany) chHBV
Ogata et al.62 (USA) HBV (experimental infection)
Vaudin et al.63 (United Kingdom) HBV (PCR)
Eichberg and Kalter64 (USA) HBV (serological tests)
Zuckerman et al.65 (United
Kingdom)
HBV (serological tests)
Starkman et al.23 (Taiwan – tested
in United Kingdom)
Pongo pygmaeus
spp.
32/104 58/141–1/14 –
Davis et al.66 (Canada) –
Warren et al.31 (Indonesia) orHBV
Vaudin et al.63 (United Kingdom) HBV (PCR)
Sall et al.67 (Cambodia) Hylobates spp. 66/211 53/225–48/130 gbHBV
Starkman et al.23 (Taiwan – tested
in United Kingdom)
gbHBV
Aiba  et al.68 (Japan) gbHBV
Noppornpanth et al.69 (Thailand) gbHBV
Grethe et al.30 (Germany, France,
Thailand, and Vietnam–tested in
Germany)
gbHBV
Thornton et al.70 (United Kingdom) gbHBV
Lanford et al.25 (USA) HBV (PCR)
Norder et al.71 (Thailand–tested in
USA)
gbHBV
Vaudin et al.63 (United Kingdom) HBV (PCR)
Lyons et al.22 (Cameroon – tested
in United Kingdom)
Gorilla gorilla
spp.
14/68 5/55–0/14 goHBV.  Evidence for a
recombination  between goHBV
and ch-derived HBV
Njouom et al.59 (Cameroon) goHBV
Makuwa et al.60 (Republic of Congo
and Gabon)
–
Thornton et al.70 (United Kingdom) goHBV
Grethe et al.30 (Germany) goHBV
Zuckerman et al.65 (United
Kingdom)
HBV (serological tests)
Old world monkeys
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Table 1 (Continued)
Publications Non-human primates
species
PCRa HBsAga–HBcAba Genotypes and observations
Dickens, 201378 (South Africa) Papio  spp. 19/97 0/176–4/111 HBV, subgenotype A2
Lyons et al.22 (Cameroon – tested
in United Kingdom)
–
Baptista  et al.72 (South Africa) HBV (experimental infection)
Michaels et al.73 (USA) –
Eichberg and Kalter64 (USA) HBV (serological tests)
Dupinay et al.35 (Mauritius Island) Cercopithecus
spp.
0/37 0/121–0/102 –
Lyons et al.22 (Cameroon – tested
in United Kingdom)
–
Makuwa et al.60 (Republic of Congo
and Gabon)
–
Starkman et al.23 (Cameroon and
Nigeria – tested in United
Kingdom)
–
Eichberg  and Kalter64 (USA) –
Lyons et al.22 (Cameroon – tested
in United Kingdom)
Mandrillus spp. 1/109 0/252–0/252 Incomplete data
Starkman et al.23 (Cameroon and
Nigeria – tested in United
Kingdom)
–
Makuwa  et al.60 (Republic of Congo
and Gabon)
Miopithecus talapoin – 0/5–0/5 –
Lyons et al.22 (Cameroon – tested
in United Kingdom)
Cercocebus
(Lophocebus)
albigena
1/14 0/6–0/6 Incomplete  data
Makuwa et al.60 (Republic of Congo
and Gabon)
–
Makuwa et al.60 (Republic of Congo
and Gabon)
Chlorocebus aethiops – 0/29–0/29 –
Dupinay et al.35 (Mauritius Island) Macaca  spp. 31/120 0/223–0/223 Sequence  was close to HBV
genotype  D subtype ayw3
Lyons et al.22 (Cameroon – tested
in United Kingdom)
–
Lyons  et al.22 (Cameroon – tested
in United Kingdom)
Erythrocebus patas 0/3 – –
New world monkeys
Lanford et al.32 (USA) Lagothrix lagotricha 10/35 7/31–X WMHBV
Eichberg and Kalter64 (USA) Saimiri sciureus – 0/20–X –
Eichberg and Kalter64 (USA) Callithrix jacchus – 0/6–X –
– Eichberg and Kalter64 (USA) Saguinus oedipus 
a Positives/tested.
infected with different types of isolates,27 supporting the
concept  that these viruses may  have evolved with their
hosts.  However, the hepadnavirus isolated from woolly mon-
keys  (Lagothrix lagotricha) – woolly monkey HBV (WMHBV)
clearly is a new member of the Hepadnaviridae family.32 Both
the  WMHBV and the New World human HBV genotypes F
and  H were  in a phylogenetic sister-relationship which is
more  divergent to the Old World human HBV genotypes,
strengthening hypotheses on an origin of HBV in New World
primates.33,34 Until the present moment, WMHBV has been
detected only in captive animals at one zoo, but it was not
found  in another four zoos tested.32 So far, there have been
no  reports about the presence of this virus in wild woolly
monkeys.0/12–X –
In 2013, Dupinay et al.35 investigated HBV infection in small
primates  of different origins and in Mauritius, 25.8% (in serum)
and  42% (in liver) of HBV DNA positives were  found. Genome
sequencing data revealed that it was human HBV genotype
D,  subtype ayw3. This provides evidence for the existence of
small  model simian chronic HBV infection, immunologically
near human and that it might have been transmitted from
man  hundred years ago.
Theories  of  HBV  origins  and  evolutionWith the advent of the new ﬁeld of paleovirology, studies have
revealed  that integration into the nuclear genome of germline
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GER (3 Pub.)
JPN (1 Pub.)
TWN (2 Pub.)
THA (1 Pub.)
KHM (1 Pub.)
VNM (1 Pub.)
IDN (1 Pub.)
=1
=1
=1
=1
=1
=1
=1
GBR (3 Pub.)
FRA (1 Pub.)
USA (8 Pub.)
CAN (1 Pub.)
=4
=1
=2
=1
=1
SLE (1 Pub.)
LBR (1 Pub.)
GAB (2 Pub.)
Pan troglodytes spp. Cercocebus (lophocebus) albigena
Macaca spp.
Lagothrix lagotricha
Pongo pygmaeus spp.
Hylobates spp.
Gorilla gorilla spp.
Papio spp.
Mandrillus spp.
COG (3 Pub.)
=1
=1
=1
=1
=1
97
97
98
98
0.02
95
100
100
100
MUS (1 Pub.)
HBV/Orangutan/AF193863
HBV/Gibbon/U46935
HBV/Homsap/J/Borneo/AB486012
HBV/Chimpanzee/AF305327
HBV/Gorilla/AJ131567
HBV/ADW2/A/AM282986
HBV/Homsap/B1/Japan/D23678
HBV/Homsap/I/Vietnam/AF241409
HBV/Homsap/C1/Cambodia/AB117758
HBV/Homsap/D/Russia/AB126581
HBV/Homsap/E/Ghana/AB205192
HBV/Homsap/G/AF160501
HBV/Homsap/F4/X69798
HBV/Homsap/H/Nicaragua/AY090454
HBV/woollymonkey/AF046996
ZAF (1 Pub.)
CRM (5 Pub.)
=1
=1
=1
=1 =1
=1
=1
=1
=1
=1
=1
=1
=1
=1
=1
=1
a
b
Fig. 1 – (A) Geographical distribution of publication relating to non-human primates which were  detected with some HBV
genotype. Sample animals are listed by genera in Table 1. (B) The evolutionary history was  inferred by Neighbor–Joining
method.74 The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000
replicates)  are shown above the branches.75 The tree is drawn to scale, with branch lengths in the same units as those of the
evolutionary distances used to infer the phylogenetic tree. The evolutionary distances were  computed using the p-distance
method76 and are in the units of number of base difference per site. All positions containing gaps and missing data were
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oliminated.  There were  a total of 3167 positions in the ﬁnal 
ells can lead to vertical inheritance of retroviral genes as
ost  alleles. Such integration events are referred to as endoge-
ous  viral elements (EVEs). Paleoviral “fossils” were recently
iscovered from a wide range of viruses including EVE non-
etroviral  families (rtDNA viruses) e.g.: Hepadnaviridae.36,37
enomic “fossils” of avihepadnaviruses integrated into the
enomes  of diverse avian species suggest that the origin of
his  group is much  older dating back several million years
o  the Mesozoic Era.38–40 In a recent study, Suh et al.40
mphasized that “insights into long-term sequence evolution,
enome  evolution and hypothetical ancestral hosts change
he  understanding of the prehistoric evolution of Hepadnaviri-
ae,  including the hypothetical origin of mammalian HBVs,”
ontributing to several studies in the ﬁeld of medical and pale-
ntological  research. The evolutionary origin of hepadnaviruset. evolutionary analyses were conducted in MEGAS.77
in  primates has been dated back several thousand years.33 No
“fossil”  records have been described from primates so far.
Most  of our knowledge about pathogenesis and the repli-
cation  of hepatitis B virus has been obtained from studies
of  hepadnaviruses related to animals as models, including
Duck  Hepatitis B Virus (DHBV),41 Woodchuck Hepatitis virus
(WHV),42 Ground Squirrel Hepatitis virus (GSHV),43 Arctic
Squirrel Hepatitis virus (ASHV),44 Heron Hepatitis B Virus
(HHBV),45 and Stork Hepatitis B Virus (STHBV).46
Studies about pathogens that affect primates are of great
scientiﬁc  relevance because of their evolutionary relation-
ship  with humans. Non-human primates can be sentinels
for  surveillance of infectious agents and also biological mod-
els  for important diseases affecting the human species,
such  as HBV. Checking for diseases common to humans
i s . 2 0540  b r a z j i n f e c t d 
and primates is crucial in reducing risks to the health of
humans.47
All known hepadnaviruses that affect primates and other
animals  cause acute and chronic hepatic infection in their
hosts.48 A main characteristic of all the viruses in this fam-
ily  is the possibility of chronic infection with serious clinical
consequences.48,49 However, what are the implications of the
origins  of HBV?
During  the 1990s, three competing hypotheses about the
evolutionary origins of HBV emerged, as reviewed by Sim-
monds  in 2001.24 A New World origin was  proposed because of
the  phylogenetic co-segregation between the New World HBV
genotypes F and H and WMHBV in basal sister-relationship,
to the Old World non-human primates and human HBV vari-
ants.  The dissemination of HBV into the Old World would then
have  occurred either in the post-Columbian Era (nearly 500
years  ago) or during earlier human migrations about 15,000
years  ago.33,34 A second theory suggests an Old World origin
of  HBV, and that it was  spread following prehistoric human
migrations over 100,000 years ago.50 A third theory suggests a
co-speciation of HBV in non-human primate hosts because of
the  proximity between the phylogeny of Old and New World
NHP  and their HBV variants.28
These theoretical approaches were  unable to reconcile con-
ﬂicting  data resultant from the distribution of HBV variants in
human and non-human primate hosts on a global scale. An
example  is that the HBV genotypes in Old World primates are
mutually  equidistant. This is unlikely to have occurred from
independent acquisitions of human HBV variants in only a few
hundred  years, going against the New World origin theory.24
In relation to the theory of a supposed exodus of HBV together
with  human migration out of Africa to other areas of the planet
does  not explain the distribution of HBV genotypes in the
world.24 For example, the New World HBV genotype F that is
found  in Native Americans is also found in genetically unre-
lated  island populations of Polynesia. The closest relatives of
Native  Americans living in Northeastern Asia are predomi-
nantly  infected by genotypes B and C of HBV.24
The widely host-speciﬁc HBV variants support the the-
ory  about HBV co-speciation with primate hosts. However, as
noted by Simmonds,24 this theory is challenged by a lack of
shared  HBV variants between humans and non-human pri-
mates,  by the existence of cross-species HBV transmission
and by the lack of higher diversiﬁcation in NHP compared to
human HBV variants. These have long been deemed unlikely,
but  recent data has shown that orangutans and gibbons shar-
ing  habitats in Asia harbour phylogenetically co-segregating
HBV variants. Similarly, recombination events between HBV
genotypes  of chimpanzee and gorilla from Central Africa, phy-
logenetically grouped together and inter-species have been
described.22,23 Furthermore, sporadic detections of human-
related HBV genotypes have been described in chimpanzees
and  Orangutans, both of the Hominidae family.9,51 Cui52
suggests that a large number of cross-species transmis-
sion  events are probably also present in avihepadnaviruses,
whose phylogeny does not match that of the host orders
52Gruiformes and Anseriformes. Gibbons separated geneti-
cally  from orangutans, gorillas and chimpanzees about 20
million  years ago. Despite this, the orangutan and gibbon HBV
variants found to date are similar.22 1 4;1  8(5):535–543
Evidence of animals as reservoirs, possible recombination
between human and non-human primate HBV variants, and
inter-species  transmissions all provide important informa-
tion  that may  assist in the eradication of HBV throughout the
world.28
Co-evolution of HBV variants in non-human primates is
further  challenged by the comparable degree of diversiﬁca-
tion  within viruses that affect chimpanzees, gibbons and
gorillas,  and phylogenetic sister-relationships between these
viruses  that do not reﬂect the evolution of their hosts. This
includes  the absence of outlier gorilla HBV variants in rela-
tion  to chimpanzee variants and human HBV genotypes F
and  H in phylogenetic outlier position to the Old World NHP
viruses.22 Similarly, this theory fails to explain the position of
gibbon  HBV variants and their comparable diversiﬁcation to
other primate HBV genotypes (phylogenetically), while they
should  be more  diversiﬁed than those of great apes given their
divergence  from the latter about twenty million years ago.52
Co-evolution on the scale of the Hepadnaviridae family seems
even  less likely, given the high diversity of rodent and bird hep-
adnaviruses from their primate counterparts. As noted above,
this  does not match the timescale of the likely separation of
these  variants, which may  be only 10–20 times greater than
the  development of monkey.22
Attempts to determine a non-recent Hepadnaviridae evo-
lution  are compromised by several factors. This includes
the  sequence constraints arising from largely overlapping
ORFs.33 While this technical problem can be dealt with,33 there
are  several recent descriptions of avihepadnavirus genomic
fossils.38,39,53 These sequences have indicated that previous
assumptions based on existent HBV variants may  have under-
estimated  the period of hepadnaviruses origin in the range
of  several million years.38 Theoretically, a continuous appear-
ance  of infectious viruses from genomic pockets could explain
the  unusually slow rates of sequence change in the range of
10  per site per year observed that are necessary to explain
the  sequence divergence between non-human primates HBV
hosts  in a co-speciation scenario.24,33
Understanding the relationship between humans and NHP
variants  of HBV will help explain the possible role that humans
and  other primates have played in the spread of HBV around
the  globe.22 No hepadnavirus elements in primate genomic
data  have been described to date. It is clear that one single
theory  has been unable to explain the emergence of HBV until
now.
Primates  in  South  America
The most plausible scenario to explain the arrival of pri-
mates  in South America consists of a transatlantic migration
at  the end of the Eocene epoch. South American platyrrhine
primates probably dispersed from either Asian or African
catarrhine ancestors about 37–40 million years ago. How-
ever,  the radiation of platyrrhines in the New World probably
occurred  during the Miocene epoch,52,54 although the feasibil-
ity  of this route is the subject of several debates. The oldest
primate  fossil discovered in South America is dated to about
27  million years ago.50 Whether Old World hepadnaviruses
could have been taken to today’s South America by the natural
b r a z j i n f e c t d i s . 2 0 1 4;1 8(5):535–543  541
Fig. 2 – In green and yellow, the geographic distribution of non-human primates52,54,56,57. In yellow, Brazil which has large
range  of species and subspecies of neotropical non-human primates in the wild fauna, representing approximately 21% of
the  group in the world.56,57
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rarriers formed by the separation of the sub-continent from
he  Gondwanan supercontinent about 100 million years ago28
s something that remains unknown. Hypothetical viruses
ould  then have been passed to several host lineages, because
 South American evolution of platyrrhines 100 million years
go  is deemed highly unlikely.28
The high degree of complexity in epidemiological factors
uch  as transmission routes can affect the large number of
BV  variants in circulation. However, the propagation of these
iruses  can be enhanced with the development of recom-
inant  variants, allowing the virus to be transmitted more
fﬁciently  between different species.10,55
There are many  primates in South America, and in
razil  alone 133 species and subspecies of Neotropical pri-
ates  can be found in the wild fauna, which represents
pproximately 21% of the existing group on the planet56
Fig. 2). Wild cycles and urban cycles of transmission of some
athogens  start to intertwine forming new epidemiological
ettings with risks to human and animal populations in both
nvironments.57,58
Until now there has been no study into infectious hepad-
avirus in non-human primates of the fauna in South America
nd  it is not known whether the existing species in the New
orld  may  or may  not be carrying the hepatitis B virus that
nfects  humans, or if it is another variant of the Hepadnaviri-
ae  family. Therefore, to investigate the presence of these
iruses  in this area it is important to try to help unravel the ori-
in  of the Hepadnaviruses and how they evolved in primates
nd  humans.Conﬂicts  of  interest
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